Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Metall ZugLTS:0QLX 63 3-Year ROIIC % is 1,184.56 as of Dec. 2025, which is 83320% above its 10-year median of 1.42. GuruFocus rates LTS:0QLX with a GF Score™ of 63/100 and a GF Value™ of CHF762.04 (Fairly Valued). The stock has 3 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Metall Zug ranks better than 98.12% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Metall Zug's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 1,184.56%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Metall Zug's 3-Year ROIIC % or its related term are showing as below:
LTS:0QLX's 3-Year ROIIC % is ranked better than 98.12% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 1.615
vs LTS:0QLX: 1184.56
Metall Zug (LTS:0QLX) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Metall Zug 3-Year ROIIC % Related Terms
Metall Zug 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Metall Zug's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0QLX vs ABT, SYK, MDT: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, Metall Zug's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metall Zug 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Metall Zug's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Metall Zug's 3-Year ROIIC % falls into.
Metall Zug's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -26.314 (Dec. 2025) - 28.4954445 (Dec. 2022) )
/
( 643.377 (Dec. 2025) - 648.004 (Dec. 2022) )
=
-54.8094445
/
-4.627
=
1,184.56%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Metall Zug (LTS:0QLX) has a 3-Year ROIIC % of 1,184.56 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Metall Zug and its competitors. This is 83320% above median its historical median of 1.42. According to the industry distribution chart, Metall Zug ranks #15 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 1.9%.
Is Metall Zug's 3-Year ROIIC % too high?
Metall Zug's current 3-Year ROIIC % of 1,184.56 is 83320% above median its 10-year median of 1.42. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.62. Metall Zug's value of 1,184.56 is 73247.4% above this industry median. Based on the distribution chart, Metall Zug ranks #15 out of 796 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Metall Zug has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Metall Zug's 3-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Metall Zug ranks #15 out of 796 companies for 3-Year ROIIC %. This places Metall Zug in the top 2% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.62. Metall Zug's value of 1,184.56 is 73247.4% above this benchmark. While the company's 10-year median is 1.42 vs. the industry median of 1.62, Metall Zug has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.62, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Metall Zug's current 3-Year ROIIC % of 1,184.56 is 73247.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Metall Zug and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metall Zug's current 3-Year ROIIC % is 1,184.56, which is 83320% above median its own 10-year median of 1.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metall Zug stock overvalued right now?
Based on GuruFocus' analysis, Metall Zug (LTS:0QLX) is currently considered Fairly Valued. The stock's GF Value™ is CHF762.04, compared to a current price of CHF729.00 — trading 4.3% below its estimated fair value. The current 3-Year ROIIC % is 1,184.56, which is 83320% above median its 10-year median of 1.42 and 73247.4% above the Medical Devices & Instruments industry median of 1.62. Metall Zug's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Metall Zug (LTS:0QLX), the current 3-Year ROIIC % is 1,184.56 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Metall Zug (LTS:0QLX) Overvalued in 2026?
Based on GuruFocus' analysis, Metall Zug stock appears to be undervalued.
The current stock price of CHF729.00 is trading 4.3% below its estimated GF Value™ of CHF762.04.
GuruFocus considers Metall Zug to be Fairly Valued.
Key valuation signals for LTS:0QLX:
3-Year ROIIC %: 1,184.56 (83320% above median its 10-year median of 1.42)
GF Value™: CHF762.04 vs. price of CHF729.00 (4.3% below fair value)
Industry Position: 73247.4% above the Medical Devices & Instruments median (#15 of 796)
No single metric tells the full story. See the LTS:0QLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Metall Zug Ltd is engaged in the industrial sector. The company is organized, into business segments namely; Medical Devices which comprises of products and services for diagnosis and surgery, mainly in the fields of ophthalmology and microsurgery; Technologycluster & Infrastructure is engaged in Management and development of real estate; and Investments & Corporate. The majority of its revenue is generated from the Medical Devices segment. Geographically, the company operates in Switzerland, Europe (excluding Switzerland), the Americas, and Asia /Pacific/Others, and the majority of its revenue is generated from the Americas region.
63GF Score
Get the complete analysis for LTS:0QLX
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QLX has been successfully added to your 
